SCHIZOPHRENIA 1 (DISORDER)
Clinical trials for SCHIZOPHRENIA 1 (DISORDER) explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA 1 (DISORDER) trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA 1 (DISORDER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a probiotic ease antipsychotic side effects? small trial hints at hope
Disease control CompletedThis study tested whether adding a probiotic called Pediococcus acidilactici to standard antipsychotic medication could reduce metabolic problems like high cholesterol and blood sugar in people with early schizophrenia. 36 adults took either the probiotic or a placebo for a perio…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: NA • Sponsor: Manuel Jesús Cuesta Zurita • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Brain zapping shows promise for multiple mental disorders
Symptom relief CompletedThis study tested a non-invasive brain stimulation method called tDCS in 320 adults with depression, schizophrenia, OCD, anxiety, or insomnia. Participants received the stimulation while researchers measured symptom changes using standard rating scales. The goal was to see if tDC…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: NA • Sponsor: Menoufia University • Aim: Symptom relief
Last updated May 26, 2026 08:34 UTC
-
Can sharing memories boost social skills in schizophrenia?
Symptom relief CompletedThis study tested whether a group reminiscence program—where people share and discuss past memories—is practical and helpful for adults hospitalized with schizophrenia. Thirty-eight participants took part in 8 weekly sessions. Researchers measured changes in thinking, communicati…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: NA • Sponsor: The Hashemite University • Aim: Symptom relief
Last updated May 26, 2026 08:30 UTC
-
New schizophrenia drug shows promise in reducing symptoms
Symptom relief CompletedThis study tested a new medication called HS-10380 in 363 adults with acute schizophrenia. The goal was to see if it reduces symptoms like hallucinations and delusions better than a placebo or an existing drug. Participants took the medicine for 6 weeks, and doctors measured chan…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Yoga and meditation show promise for schizophrenia happiness
Symptom relief CompletedThis study tested whether a 6-week mindfulness-based yoga program could improve psychological well-being and happiness in adults with schizophrenia. 91 participants from community mental health centers were randomly assigned to either the yoga program or routine care. The yoga gr…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: NA • Sponsor: Tarsus University • Aim: Symptom relief
Last updated May 18, 2026 12:13 UTC
-
Brain zaps may reveal attention secrets in schizophrenia
Knowledge-focused CompletedThis study looked at how a non-invasive brain stimulation technique called TMS affects attention and nicotine cravings in people with schizophrenia or schizoaffective disorder. Fifteen smokers aged 18-65 took part. Researchers measured brain activity and cravings before and after…
Matched conditions: SCHIZOPHRENIA 1 (DISORDER)
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 08:52 UTC